TY - THES A1 - Schneider, Felicitas Maria Hannelore T1 - Vergleichende Evaluierung verschiedener Ansätze des Memory Enhancement bei neurodegenerativen Prozessen T1 - Comparative evaluation of different approaches of memory enhancement in neurodegenerative disease N2 - Angesichts des dramatischen, weltweiten Anstiegs der Prävalenz von Demenzerkrankungen und der aktuellen, unzureichenden Therapieansätze ist die Bereitstellung neuer, wirkungsvoller Behandlungsoptionen von größter Bedeutung. Technologische, pharmakologische und verhaltensbasierte Verfahren des Memory Enhancement könnten zur Lösung dieses Problems beitragen: Hierzu zählt die Stammzelltransplantation, die in mehreren Tierstudien zu einer Verbesserung der Gedächtnisfunktion führte. Zudem wird seit Längerem an einer Impfung gegen die Alzheimer-Krankheit mittels β-Amyloid-Antikörpern geforscht. Ein weiterer therapeutischer Ansatz für die Alzheimer-Krankheit besteht in der optogenetischen Stimulation spezifischer hippocampaler Engramm-Zellen, durch die bei einem Maus-Modell verloren gegangene Erinnerungen wiederhergestellt werden konnten. Unkonventionelle Pharmazeutika wie Erythropoetin führten in Tierstudien und bei Patienten mit neuropsychiatrischen Erkrankungen zu einer Verbesserung der kognitiven Fähigkeiten und des Gedächtnisses. Eine Modifikation der Ernährung und der Einsatz von Pro- und Präbiotika beeinflussen das Gedächtnis über eine Manipulation der Darm-Hirn-Achse. Verhaltensbasierte Maßnahmen wie körperliche Aktivität und der Einsatz von Mnemotechniken stellen effektive Ansätze des Memory Enhancement dar, welche bereits heute von gesunden Individuen implementiert werden können. Für die Anwendung von Augmented Reality (AR) konnten kognitionsfördernde Wirkungen beim Lernen neuroanatomischer Themen und dem Zusammenbau von Objekten nachgewiesen werden. Besonders vielversprechend stellt sich die Entwicklung einer Gedächtnisprothese dar, durch die vergessene Informationen bei Personen mit stattgehabtem Schädel-Hirn-Trauma und apoplektischem Insult reaktiviert werden könnten. Memory Enhancement ist prinzipiell bereits heute bei gesunden und kranken Individuen anwendbar und verspricht wirksame zukünftige Präventions- und Therapieoptionen. Ein realer Einsatz in der klinischen Praxis ist in naher Zukunft jedoch noch nicht zu erwarten. N2 - Due to the worldwide increasing prevalence of dementia and the current, inadequate therapeutic approaches, it is very important to develop new, effective treatment options. Technological, pharmacological and behavior-based methods of memory enhancement could help to solve this problem: This includes stem cell transplantation, which has led to an improvement in memory function in several animal studies. In addition, research into vaccination against Alzheimer's disease using β-amyloid antibodies has been done for several years. Another therapeutic approach for Alzheimer's disease is the optogenetic stimulation of specific hippocampal engram cells, through which lost memories could be restored in a mouse model. Unconventional pharmaceuticals such as erythropoietin have improved cognitive skills and memory in animal studies and in patients with neuropsychiatric disorders. A diet modification and the use of probiotics and prebiotics affect memory by manipulating the gut-brain axis. Behavioral approaches such as physical activity and the use of mnemonics represent effective approaches of memory enhancement that healthy individuals can already implement today. The application of augmented reality (AR) was associated to cognition-promoting effects when learning neuroanatomical topics and assembling objects. The development of a memory prosthesis seems to be particularly promising and could be used to reactivate forgotten information in people with traumatic brain injury and apoplectic insult. In principle, memory enhancement can already be used today in healthy and diseased individuals and promises effective future prevention and therapy options. However, a real use in clinical practice cannot be expected in the near future. KW - Neurodegeneration KW - Langzeitgedächtnis KW - Alzheimerkrankheit KW - memory enhancement KW - neuroenhancement Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-207562 ER - TY - JOUR A1 - Matthes, Niels A1 - Diers, Johannes A1 - Schlegel, Nicolas A1 - Hankir, Mohammed A1 - Haubitz, Imme A1 - Germer, Christoph-Thomas A1 - Wiegering, Armin T1 - Validation of MTL30 as a quality indicator for colorectal surgery JF - PLoS One N2 - Background Valid indicators are required to measure surgical quality. These ideally should be sensitive and selective while being easy to understand and adjust. We propose here the MTL30 quality indicator which takes into account 30-day mortality, transfer within 30 days, and a length of stay of 30 days as composite markers of an uneventful operative/postoperative course. Methods Patients documented in the StuDoQ|Colon and StuDoQ|Rectal carcinoma register of the German Society for General and Visceral Surgery (DGAV) were analyzed with regard to the effects of patient and tumor-related risk factors as well as postoperative complications on the MTL30. Results In univariate analysis, the MTL30 correlated significantly with patient and tumor-related risk factors such as ASA score (p<0.001), age (p<0.001), or UICC stage (p<0.001). There was a high sensitivity for the postoperative occurrence of complications such as re-operations (p<0.001) or subsequent bleeding (p<0.001), as well as a significant correlation with the CDC classification (p<0.001). In multivariate analysis, patient-related risk factors and postoperative complications significantly increased the odds ratio for a positive MTL30. A negative MTL30 showed a high specify for an uneventful operative and postoperative course. Conclusion The MTL30 is a valid indicator of colorectal surgical quality. KW - surgical care KW - discharge definition KW - definition KW - mortality KW - pancreatectomy KW - complications KW - superior KW - capture Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230530 VL - 15 IS - 8 ER - TY - JOUR A1 - Kunz, Tobias C. A1 - Götz, Ralph A1 - Gao, Shiqiang A1 - Sauer, Markus A1 - Kozjak-Pavlovic, Vera T1 - Using Expansion Microscopy to Visualize and Characterize the Morphology of Mitochondrial Cristae JF - Frontiers in Cell and Developmental Biology N2 - Mitochondria are double membrane bound organelles indispensable for biological processes such as apoptosis, cell signaling, and the production of many important metabolites, which includes ATP that is generated during the process known as oxidative phosphorylation (OXPHOS). The inner membrane contains folds called cristae, which increase the membrane surface and thus the amount of membrane-bound proteins necessary for the OXPHOS. These folds have been of great interest not only because of their importance for energy conversion, but also because changes in morphology have been linked to a broad range of diseases from cancer, diabetes, neurodegenerative diseases, to aging and infection. With a distance between opposing cristae membranes often below 100 nm, conventional fluorescence imaging cannot provide a resolution sufficient for resolving these structures. For this reason, various highly specialized super-resolution methods including dSTORM, PALM, STED, and SIM have been applied for cristae visualization. Expansion Microscopy (ExM) offers the possibility to perform super-resolution microscopy on conventional confocal microscopes by embedding the sample into a swellable hydrogel that is isotropically expanded by a factor of 4–4.5, improving the resolution to 60–70 nm on conventional confocal microscopes, which can be further increased to ∼ 30 nm laterally using SIM. Here, we demonstrate that the expression of the mitochondrial creatine kinase MtCK linked to marker protein GFP (MtCK-GFP), which localizes to the space between the outer and the inner mitochondrial membrane, can be used as a cristae marker. Applying ExM on mitochondria labeled with this construct enables visualization of morphological changes of cristae and localization studies of mitochondrial proteins relative to cristae without the need for specialized setups. For the first time we present the combination of specific mitochondrial intermembrane space labeling and ExM as a tool for studying internal structure of mitochondria. KW - Expansion microscopy KW - mitochondria KW - cristae KW - structured illumination microscope KW - ultrastructure Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-208296 SN - 2296-634X VL - 8 ER - TY - THES A1 - Pfann, Christina T1 - Untersuchungen zu neuen therapeutischen Ansätzen zur Beeinflussung der MYC-Expression im kolorektalen Karzinom T1 - Experiments on new therapeutic strategies to influence MYC expression in colorectal cancer N2 - Eine veränderte Expression des Transkriptionsfaktors MYC wird als entscheidender Faktor für Tumorentstehung und -progress im kolorektalen Karzinom gesehen. Somit ist die Hemmung dessen Expression und Funktion ein zentraler Ansatz bei der zielgerichteten Tumortherapie. Als geeignete Strategie, sowohl die Halbwertszeit als auch die Translation von MYC zu verringern, erschien eine duale PI3K-/mTOR-Hemmung durch den small molecule-Inhibitor BEZ235. Gegenteilig ist jedoch unter Behandlung mit BEZ235 eine verstärkte MYC-Expression in verschiedenen Kolonkarzinom-Zelllinien zu beobachten. Neben verstärkter Transkription, konnte eine verstärkte IRES-abhängige Translation von MYC nach Hemmung der mTOR-/5´Cap-abhängigen Translation durch BEZ235, als Ursache der MYC-Induktion nachgewiesen werden. Es konnte gezeigt werden, dass die Induktion von MYC nach PI3K-/mTOR-Hemmung durch eine kompensatorische Aktivierung des MAPK-Signalwegs in Folge einer FOXO-abhängigen Induktion von Rezeptortyrosinkinasen, stattfindet. Eine mögliche Strategie, diese Feedback-Mechanismen zu umgehen, ist die direkte Hemmung der Translationsinitiation. Hierfür wurden Rocaglamid und dessen Derivat Silvestrol als small molecule-Inhibitoren der eIF4A-Helikase verwendet. Im Gegensatz zur PI3K/mTOR-Hemmung, ist durch eIF4A-Inhibition eine Reduktion der MYC-Proteinexpression in verschiedenen Kolonkarzinom-Zelllinien zu erreichen – ohne einhergehende MAPK-Aktivierung. Anhand der Ergebnisse kann postuliert werden, dass Silvestrol das Potential besitzt, sowohl die Cap-/eIF4F-abhängie als auch die somit eIF4A-abhängige IRES-vermittelte Translation von MYC zu hemmen. Weiterhin kann eine proliferationshemmende Wirkung durch Silvestrol auf Kolonkarzinom-Zellen in vitro, via Zellzyklusarrest und Induktion von Apoptose, gezeigt werden. Dies stellt die Voraussetzung für eine potentielle Eignung als tumorhemmender Wirkstoff in der Therapie des kolorektalen Karzinoms dar. N2 - Deregulated expression of MYC is a driver of colorectal carcinogenesis. Thus inhibition of MYC function and expression may be a central aim in targeted therapy. Inhibiting the PI3K-and mTOR pathway seemed to be a proper strategy to increase MYC turnover and reduce its translation. Instead, we observe enhanced MYC expression in colon carcinoma cells upon treatment with the dual PI3K-/mTOR-inhibitor BEZ235. PI3K-/mTOR-Inhibition permits both enhanced transcription and induction of IRES-dependent translation of MYC through feedback activation of the MAPK pathway via FOXO-dependent induction of receptor tyrosine kinases. A strategy to bypass the signalling feedback mechanisms, is targeting the translation initiation. Using Silvestrol, a Rocaglamid derivate as small molecule inhibitor of the initiation factor eIF4A, MYC protein expression can be reduced in colorectal cancer cells – without observed MAPK-activation. So Silvestrol has he potential to inhibit Cap-/eIF4F-dependend as well as eIF4A-dependent IRES-mediated tranlation of MYC. Furthermore Silvestrol inhibits proliferation of colon carcinoma cells in vitro, shown by cell cycle arrest and induction of apoptosis. Our data argue that targeting translation initiation is a promising strategy to limit MYC expression in colorectal cancer. Thus, together with its antiproliferative effect, Silvestrol might be a potential anti-tumor agent. KW - Myc KW - colorectal cancer Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-216687 ER - TY - JOUR A1 - Rabl, Dominik A1 - Alonso-Rodríguez, Aura M. A1 - Brehm, Gunnar A1 - Fiedler, Konrad T1 - Trait variation in moths mirrors small-scaled ecological gradients in a tropical forest landscape JF - Insects N2 - Along environmental gradients, communities are expected to be filtered from the regional species pool by physical constraints, resource availability, and biotic interactions. This should be reflected in species trait composition. Using data on species-rich moth assemblages sampled by light traps in a lowland rainforest landscape in Costa Rica, we show that moths in two unrelated clades (Erebidae-Arctiinae; Geometridae) are much smaller-sized in oil palm plantations than in nearby old-growth forest, with intermediate values at disturbed forest sites. In old-growth forest, Arctiinae predominantly show aposematic coloration as a means of anti-predator defense, whereas this trait is much reduced in the prevalence in plantations. Similarly, participation in Müllerian mimicry rings with Hymenoptera and Lycidae beetles, respectively, is rare in plantations. Across three topographic types of old-growth forests, community-weighted means of moth traits showed little variation, but in creek forest, both types of mimicry were surprisingly rare. Our results emphasize that despite their mobility, moth assemblages are strongly shaped by local environmental conditions through the interplay of bottom–up and top–down processes. Assemblages in oil palm plantations are highly degraded not only in their biodiversity, but also in terms of trait expression. KW - Costa Rica KW - body size KW - mimicry rings KW - aposematism KW - oil palm plantations KW - lowland rainforest Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-213016 SN - 2075-4450 VL - 11 IS - 9 ER - TY - THES A1 - Eidel, Matthias T. A. M. T1 - Training Effects of a Tactile Brain-Computer Interface System During Prolonged Use by Healthy And Motor-Impaired People T1 - Trainingseffekte eines Taktilen Brain-Computer Interface Systems bei längerer Nutzung von gesunden sowie motorisch eingeschränkten Personen N2 - Background - Brain-Computer Interfaces (BCI) enable their users to interact and communicate with the environment without requiring intact muscle control. To this end, brain activity is directly measured, digitized and interpreted by the computer. Thus, BCIs may be a valuable tool to assist severely or even completely paralysed patients. Many BCIs, however, rely on neurophysiological potentials evoked by visual stimulation, which can result in usability issues among patients with impaired vision or gaze control. Because of this, several non-visual BCI paradigms have been developed. Most notably, a recent study revealed promising results from a tactile BCI for wheelchair control. In this multi-session approach, healthy participants used the BCI to navigate a simulated wheelchair through a virtual apartment, which revealed not only that the BCI could be operated highly efficiently, but also that it could be trained over five sessions. The present thesis continues the research on this paradigm in order to - confirm its previously reported high performance levels and trainability - reveal the underlying factors responsible for observed performance increases - establish its feasibility among potential impaired end-users Methods - To approach these goals, three studies were conducted with both healthy participants and patients with amyotrophic lateral sclerosis (ALS). Brain activity during BCI operation was recorded via electroencephalography (EEG) and interpreted using a machine learning-based linear classifier. Wheelchair navigation was executed according to the classification results and visualized on a monitor. For offline statistical analysis, neurophysiological features were extracted from EEG data. Subjective data on usability were collected from all participants. Two specialized experiments were conducted to identify factors for training. Results and Discussion - Healthy participants: Results revealed positive effects of training on BCI performances and their underlying neurophysiological potentials. The paradigm was confirmed to be feasible and (for a non-visual BCI) highly efficient for most participants. However, some had to be excluded from analysis of the training effects because they could not achieve meaningful BCI control. Increased somatosensory sensitivity was identified as a possible mediator for training-related performance improvements. Participants with ALS: Out of seven patients with various stages of ALS, five could operate the BCI with accuracies significantly above chance level. Another ALS patient in a state of near-complete paralysis trained with the BCI for several months. Although no effects of training were observed, he was consistently able to operate the system above chance level. Subjective data regarding workload, satisfaction and other parameters were reported. Significance - The tactile BCI was evaluated on the example of wheelchair control. In the future, it could help impaired patients to regain some lost mobility and self-sufficiency. Further, it has the potential to be adapted to other purposes, including communication. Once visual BCIs and other assistive technologies fail for patients with (progressive) motor impairments, vision-independent paradigms such as the tactile BCI may be among the last remaining alternatives to interact with the environment. The present thesis has strongly confirmed the general feasibility of the tactile paradigm for healthy participants and provides first clues about the underlying factors of training. More importantly, the BCI was established among potential end-users with ALS, providing essential external validity. N2 - Hintergrund - Brain-Computer Interfaces (BCI) ermöglichen ihren Benutzern die Interaktion und Kommunikation mit der Außenwelt, ohne dabei die Funktionstüchtigkeit der Muskeln voraus zu setzen. Zu diesem Zweck wird die Gehirnaktivität vom Computer direkt gemessen, digitalisiert und schließlich interpretiert. BCIs könnten daher eine wertvolle Methode sein, schwer körperlich beeinträchtigten oder sogar vollständig gelähmten Patienten zu assistieren. Viele BCI Ansätze basieren allerdings auf neurophysiologischen Potentialen, welche mittels visueller Stimulation evoziert werden. Dies kann zur Folge haben, dass das BCI von Patienten mit Sehbehinderung oder fehlender Kontrolle über die eigene Blickrichtung nicht erfolgreich benutzt werden kann. Deshalb wurden bereits einige nicht-visuelle BCI Paradigmen entwickelt. Insbesondere eine aktuelle Studie über ein taktiles BCI zur Rollstuhlkontrolle lieferte vielversprechende Ergebnisse: In fünf Trainingssitzungen navigierten gesunde Studienteilnehmer per BCI einen simulierten Rollstuhl durch eine virtuelle Wohnung. Hierbei konnte gezeigt werden, dass das BCI System nicht nur sehr effizient genutzt werden konnte, sondern auch, dass sich die Kontrolle durch das Training über mehrere Sitzungen verbesserte. Die vorliegende Dissertation befasst sich mit der weiterführenden Erforschung eben dieses Paradigmas, insbesondere mit den Zielen: . die zuvor berichtete hohe Performanz und Trainierbarkeit zu bestätigen . aufzuklären, welche Faktoren der Steigerung der BCI-Leistung zugrunde liegen . die Anwendbarkeit des Paradigmas bei beeinträchtigten Endnutzern zu etablieren Methoden - Um diese Ziele zu erreichen wurden drei Studien sowohl mit gesunden als auch mit Teilnehmern mit amyotropher Lateralsklerose (ALS) durchgeführt. Während der BCI-Nutzung wurde die Gehirnaktivität per Elektroenzephalographie (EEG) aufgezeichnet und von einem linearen Klassifikator (basierend auf Maschinenlernverfahren) interpretiert. Die Navigation des Rollstuhls wurde entsprechend der Ergebnisse des Klassifikators umgesetzt und auf einem Bildschirm visualisiert. Zur späteren statistischen Analyse wurden aus den EEG Daten neurophysiologische Merkmale extrahiert. Zudem wurden Fragebogendaten zur Nutzbarkeit des Systems von allen Teilnehmern erhoben. Zwei Experimente zur Identifizierung von Trainingsfaktoren wurden durchgeführt. Ergebnisse und Diskussion - Gesunde Teilnehmer: Die Ergebnisse zeigten positive Effekte des Trainings auf die BCI Performanz und deren zugrundeliegenden neurophysiologischen Potentiale. Es konnte bestätigt werden, dass das Paradigma anwendbar und für die meisten Teilnehmer hocheffizient nutzbar war (im Vergleich zu anderen nicht-visuellen Ansätzen). Einige Teilnehmer mussten jedoch von der Analyse der Trainingseffekte ausgeschlossen werden, da sie keine ausreichende Kontrolle über das BCI ausüben konnten. Eine Steigerung der somatosensorischen Empfindlichkeitsschwelle wurde als ein möglicher Faktor für die Trainierbarkeit und Verbesserung der Performanz identifiziert. Teilnehmer mit ALS: Fünf von sieben Teilnehmern in verschiedenen ALS-Stadien konnten das BCI signifikant überzufällig benutzen. Ein weiterer ALS Patient mit nahezu vollständiger Lähmung trainierte den Umgang mit dem BCI über mehrere Monate hinweg. Er war beständig in der Lage, das System mit Genauigkeiten über dem Zufallsniveau zu steuern, jedoch konnten keine Trainingseffekte gezeigt werden. Fragebogendaten zur subjektiven Arbeitsbelastung, Zufriedenheit und einigen weiteren Parametern wurden ausführlich berichtet. Bedeutung - Das taktile BCI wurde am Beispiel der Rollstuhlkontrolle evaluiert. In naher Zukunft könnte es beeinträchtigten Patienten helfen, ihre verlorene Mobilität und Selbstständigkeit zurück zu erlangen. Zudem kann es für viele weitere Zwecke adaptiert werden, insbesondere zur Kommunikation. Sobald visuelle BCIs oder andere technische Hilfsmittel bei Patienten mit (progressiver) motorischer Lähmung scheitern, könnten nicht-visuelle Paradigmen wie das taktile BCI zu den letzten verbleibenden Alternativen gehören, die eine Interaktion mit der Außenwelt noch erlauben. Die vorliegende Arbeit hat die grundsätzliche Anwendbarkeit des taktilen Paradigmas für gesunde Benutzer klar bestätigt. Zudem liefert sie erste Hinweise darauf, welche Faktoren den beobachteten Trainingseffekten zugrunde liegen könnten. Das BCI hat sich zudem bei potentiellen End-Nutzern mit ALS bewährt, was der externen Validität der Studienergebnisse enorm zuträgt. KW - Myatrophische Lateralsklerose KW - Gehirn-Computer-Schnittstelle KW - Elektroencephalographie KW - Rollstuhl KW - Brain-Computer Interface KW - Amyotrophic Lateral Sclerosis KW - Wheelchair Navigation Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-208511 ER - TY - JOUR A1 - Biscotti, Maria Assunta A1 - Carducci, Federica A1 - Barucca, Marco A1 - Gerdol, Marco A1 - Pallavicini, Alberto A1 - Schartl, Manfred A1 - Canapa, Adriana A1 - Contar Adolfi, Mateus T1 - The transcriptome of the newt Cynops orientalis provides new insights into evolution and function of sexual gene networks in sarcopterygians JF - Scientific Reports N2 - Amphibians evolved in the Devonian period about 400 Mya and represent a transition step in tetrapod evolution. Among amphibians, high-throughput sequencing data are very limited for Caudata, due to their largest genome sizes among terrestrial vertebrates. In this paper we present the transcriptome from the fire bellied newt Cynops orientalis. Data here presented display a high level of completeness, comparable to the fully sequenced genomes available from other amphibians. Moreover, this work focused on genes involved in gametogenesis and sexual development. Surprisingly, the gsdf gene was identified for the first time in a tetrapod species, so far known only from bony fish and basal sarcopterygians. Our analysis failed to isolate fgf24 and foxl3, supporting the possible loss of both genes in the common ancestor of Rhipidistians. In Cynops, the expression analysis of genes described to be sex-related in vertebrates singled out an expected functional role for some genes, while others displayed an unforeseen behavior, confirming the high variability of the sex-related pathway in vertebrates. KW - developmental biology KW - evolution Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227326 VL - 10 ER - TY - JOUR A1 - Jessen, Christina A1 - Kreß, Julia K. C. A1 - Baluapuri, Apoorva A1 - Hufnagel, Anita A1 - Schmitz, Werner A1 - Kneitz, Susanne A1 - Roth, Sabine A1 - Marquardt, André A1 - Appenzeller, Silke A1 - Ade, Casten P. A1 - Glutsch, Valerie A1 - Wobser, Marion A1 - Friedmann-Angeli, José Pedro A1 - Mosteo, Laura A1 - Goding, Colin R. A1 - Schilling, Bastian A1 - Geissinger, Eva A1 - Wolf, Elmar A1 - Meierjohann, Svenja T1 - The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression JF - Oncogene N2 - The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses the activity of the melanocyte lineage marker MITF in melanoma, thereby reducing the expression of pigmentation markers. Intriguingly, we furthermore identified NRF2 as key regulator of immune-modulating genes, linking oxidative stress with the induction of cyclooxygenase 2 (COX2) in an ATF4-dependent manner. COX2 is critical for the secretion of prostaglandin E2 and was strongly induced by H\(_2\)O\(_2\) or TNFα only in presence of NRF2. Induction of MITF and depletion of COX2 and PGE2 were also observed in NRF2-deleted melanoma cells in vivo. Furthermore, genes corresponding to the innate immune response such as RSAD2 and IFIH1 were strongly elevated in absence of NRF2 and coincided with immune evasion parameters in human melanoma datasets. Even in vitro, NRF2 activation or prostaglandin E2 supplementation blunted the induction of the innate immune response in melanoma cells. Transcriptome analyses from lung adenocarcinomas indicate that the observed link between NRF2 and the innate immune response is not restricted to melanoma. KW - NRF2 KW - melanoma malignancy KW - COX2 expression Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-235064 SN - 0950-9232 VL - 39 ER - TY - JOUR A1 - Thorn, Simon A1 - Seibold, Sebastian A1 - Leverkus, Alexandro B A1 - Michler, Thomas A1 - Müller, Jörg A1 - Noss, Reed F A1 - Stork, Nigel A1 - Vogel, Sebastian A1 - Lindenmayer, David B T1 - The living dead: acknowledging life after tree death to stop forest degradation JF - Frontiers in Ecology and the Environment N2 - Global sustainability agendas focus primarily on halting deforestation, yet the biodiversity crisis resulting from the degradation of remaining forests is going largely unnoticed. Forest degradation occurs through the loss of key ecological structures, such as dying trees and deadwood, even in the absence of deforestation. One of the main drivers of forest degradation is limited awareness by policy makers and the public on the importance of these structures for supporting forest biodiversity and ecosystem function. Here, we outline management strategies to protect forest health and biodiversity by maintaining and promoting deadwood, and propose environmental education initiatives to improve the general awareness of the importance of deadwood. Finally, we call for major reforms to forest management to maintain and restore deadwood; large, old trees; and other key ecological structures. KW - forest degradation KW - biodiversity KW - deadwood Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-218575 VL - 18 IS - 9 SP - 505 EP - 512 ER - TY - JOUR A1 - Boschert, Verena A1 - Klenk, Nicola A1 - Abt, Alexander A1 - Raman, Sudha Janaki A1 - Fischer, Markus A1 - Brands, Roman C. A1 - Seher, Axel A1 - Linz, Christian A1 - Müller-Richter, Urs D. A. A1 - Bischler, Thorsten A1 - Hartmann, Stefan T1 - The influence of Met receptor level on HGF-induced glycolytic reprogramming in head and neck squamous cell carcinoma JF - International Journal of Molecular Sciences N2 - Head and neck squamous cell carcinoma (HNSCC) is known to overexpress a variety of receptor tyrosine kinases, such as the HGF receptor Met. Like other malignancies, HNSCC involves a mutual interaction between the tumor cells and surrounding tissues and cells. We hypothesized that activation of HGF/Met signaling in HNSCC influences glucose metabolism and therefore substantially changes the tumor microenvironment. To determine the effect of HGF, we submitted three established HNSCC cell lines to mRNA sequencing. Dynamic changes in glucose metabolism were measured in real time by an extracellular flux analyzer. As expected, the cell lines exhibited different levels of Met and responded differently to HGF stimulation. As confirmed by mRNA sequencing, the level of Met expression was associated with the number of upregulated HGF-dependent genes. Overall, Met stimulation by HGF leads to increased glycolysis, presumably mediated by higher expression of three key enzymes of glycolysis. These effects appear to be stronger in Met\(^{high}\)-expressing HNSCC cells. Collectively, our data support the hypothesized role of HGF/Met signaling in metabolic reprogramming of HNSCC. KW - HNSCC KW - head and neck cancer KW - HGF KW - Met KW - cancer metabolism Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-235995 SN - 1422-0067 VL - 21 IS - 2 ER -